Table 2.
Participants’ Clinical and Social Determinant of Health Characteristics
| Social Determinant of Health Characteristics | Total Cohort (N= 93) |
|---|---|
| Age (years), median (Q1,Q3) | 62 (52.0.67.0) |
| Female, n (%) | 50 (53.8) |
| White, non-Hispanic n (%) | 75 (80.7) |
| College educated, n (%) | 62 (66.7) |
| Working for income, n (%) | 17 (18.3) |
| Private Insurance, n (%) | 41 (44.1) |
| Married/in a relationship, n (%) | 57 (61.3) |
| Primary support person, spouse/significant other, n (%) | 58 (62.4) |
| Patient reported financial status, “Does not have enough to make ends meet,” n (%) | 8 (8.6) |
| Patient reported quality of support, “satisfactory” or “poor,” n (%) | 3 (3.2) |
| SIPAT score, median (QR) | 9.0 (9.0) |
| Clinical Characteristics | |
| Restrictive Lung Disease | 48 (51.6) |
| LAS, median (Q1,Q3) | 39.43 (34.16,47.35) |
| History of Cigarette use (yes), n (%) | 24 (50.0) |
| Pack year history median (Q1,Q3) | 20 (0, 40.0) |
| BMI, median (Q1,Q3) | 26.22 (21.98, 30.74) |
| Number of prescribed medications, median (Q1,Q3) | 12 (9.0, 16.0) |
| Antidepressants use, n (%) | 32 (34.4) |
| Benzodiazepine use, n (%) | 31 (33.3) |
| Sleep Aid use, n (%) | 16 (17.2) |
| Opioid use, n (%) | 12 (12.9) |
| Oral Corticosteroid use, n (%) | 49 (52.7) |
| 6 MWT distance (meters), median (Q1,Q3) | 239.57 (164.5,315.7) |
6MWT distance= 6-minute walk test distance; BMI= Body Mass Index; IQR=interquartile range; LAS= Lung Allocation Score; SIPAT= Stanford Integrate Psychosocial Assessment for Transplant;